Prospective analysis of circulating metabolites and endometrial cancer risk.

Gynecol Oncol · 2021 · PMC8336647 · PMID 34099314

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantP-value =0.05actually significant

Serine and free carnitine (C0) showed a borderline significant inverse association with endometrial cancer risk (OR 1SD : 0.89, 95% CI: 0.79–1.00, P-value =0.05, Perm-Pvalue = 1.00 and OR 1SD : 0.91, 95% CI: 0.81–1.00, P-value =0.07, Perm-Pvalue = 0.82, respectively).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.